Status:
RECRUITING
Impact of Patient-Reported Outcomes for Symptom Monitoring in Patients Followed for Head and Neck Squamous Cell Carcinoma (HNSCC)
Lead Sponsor:
Centre Henri Becquerel
Collaborating Sponsors:
Resilience
Conditions:
Head and Neck Squamous Cell Carcinoma HNSCC
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
The use of digital strategies to systematically monitor patients' symptoms in clinical settings allows problems to be detected at an early stage before they worsen or lead to complications. In this st...
Eligibility Criteria
Inclusion
- Patient aged over 18 and under 75 years WHO score \< 2,
- Treated for localised heand and neck cancer of the squamous cell carcinoma type for which curative treatment has been chosen and receiving radiotherapy or radio-chemotherapy exclusively or as an adjuvant with the aim of cure
- Having signed the informed consent form,
- Affiliated with or beneficiary of a social protection scheme,
- Access to a smartphone or the internet,
Exclusion
- History of other neoplastic disease less than 2 years ago or progressive disease,
- History of ENT radiotherapy,
- Pregnant or breastfeeding women,
- Protected adults (under guardianship, curatorship or judicial protection),
- Patients participating in a therapeutic study,
- Patients unable to understand the study for any reason or to comply with the constraints of the trial (language, psychological or geographical issues, etc.), patients with blindness preventing the use of the medical telemonitoring solution in oncology.
Key Trial Info
Start Date :
October 15 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2030
Estimated Enrollment :
192 Patients enrolled
Trial Details
Trial ID
NCT07190755
Start Date
October 15 2025
End Date
June 1 2030
Last Update
December 30 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Henri Becquerel
Rouen, France
2
Institut de Cancérologie de Lorraine
Vandœuvre-lès-Nancy, France